Wachtell Steers Perrigo In €275M Unit Sale To Pharma Biz

By Dawood Fakhir · April 25, 2024, 6:01 PM BST

Healthcare company Perrigo said Thursday that it has agreed to sell its pharmaceutical division for rare diseases to pharmaceutical company Esteve Healthcare SL for €275 million ($295 million) in a deal...

To view the full article, register now.